Page last updated: 2024-08-21

pyrazines and thromboxane a2

pyrazines has been researched along with thromboxane a2 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's5 (62.50)18.2507
2000's1 (12.50)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, KJ; Wu, YS1
Liu, SY; Xu, YY; Zhu, JY1
Chen, S; Li, JW; Ma, SX; Wang, Y; Yan, YH1
Feng, J; Liu, R; Tang, S; Wu, G2
Feng, J; Tang, S; Wu, G1
Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J1
Chen, H; Chen, K; Chen, Y; Chu, J; Li, L; Li, Q; Liu, L; Peng, J; Shen, A1

Other Studies

8 other study(ies) available for pyrazines and thromboxane a2

ArticleYear
[Effects of a compound prescription of blood activator and tetramethylpyrazine on the biosynthesis of thromboxane A2].
    Zhong xi yi jie he za zhi = Chinese journal of modern developments in traditional medicine, 1985, Volume: 5, Issue:3

    Topics: Animals; Fibrinolytic Agents; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Plant Extracts; Plants, Medicinal; Pyrazines; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes

1985
[The effects of Salvia miltiorrhizae Bge and Ligustrazine on thromboxane A2 and prostacyclin in pregnancy induced hypertension].
    Zhonghua fu chan ke za zhi, 1994, Volume: 29, Issue:11

    Topics: Adult; Drugs, Chinese Herbal; Epoprostenol; Female; Humans; Plant Extracts; Pre-Eclampsia; Pregnancy; Pyrazines; Salvia miltiorrhiza; Thromboxane A2

1994
Effect of new thromboxane A2 synthesis inhibitor tetramethyl-pyrazine on pancreatic transplantation in diabetic rats.
    Transplantation proceedings, 1996, Volume: 28, Issue:3

    Topics: Albuminuria; Animals; Benzofurans; beta 2-Microglobulin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Organ Size; Pancreas Transplantation; Pyrazines; Rats; Rats, Wistar; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Isogeneic

1996
Pretreatment with tetramethylpyrazine increases the release of PGI2 and decreases TXA2 release in isolated rat heart.
    Planta medica, 1996, Volume: 62, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Heart; In Vitro Techniques; Male; Myocardium; Pyrazines; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Vasodilator Agents

1996
Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart.
    Molecular and cellular biochemistry, 1997, Volume: 167, Issue:1-2

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Coronary Circulation; Epoprostenol; Heart; Hypoxia; In Vitro Techniques; Male; Myocardium; Perfusion; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane B2; Time Factors; Vasodilator Agents

1997
The effects of tetramethylpyrazine on the incidence of arrhythmias and the release of PGI2 and TXA2 in the ischemic rat heart.
    Planta medica, 1999, Volume: 65, Issue:3

    Topics: Animals; Arrhythmias, Cardiac; Epoprostenol; Heart; Male; Myocardial Ischemia; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane A2

1999
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
    Nephron. Physiology, 2004, Volume: 98, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; Glomerular Basement Membrane; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Proteinuria; Pyrazines; Rats; RNA, Messenger; Thromboxane A2

2004
Ligustrazine inhibits platelet activation via suppression of the Akt pathway.
    International journal of molecular medicine, 2019, Volume: 43, Issue:1

    Topics: Animals; Calcium; Hemorrhage; Insulin-Like Growth Factor I; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; Thromboxane A2

2019